Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
about
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation.Identification of molecular markers for pre-engraftment immune reactions after cord blood transplantation by SELDI-TOF MS.Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantationHaploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.Immune Reactions following Cord Blood Transplantations in Adults.Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.Cord blood transplantation for adults.Antifungal prophylaxis following reduced-intensity stem cell transplantation.Expanding the role of umbilical cord blood transplantation.Infectious complications following unrelated cord blood transplantation.Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin.Umbilical cord blood transplantation in adult myeloid leukemia.HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.Future of cord blood for oncology uses.Reduced-intensity conditioning and umbilical cord blood transplantation in adults.Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.Phase II study of intrabone single unit cord blood transplantation for hematological malignanciesDisseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases.Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis.Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults
P2860
Q30418861-3548CCB8-BA2F-45D2-AC06-3C3E9046D23EQ33367345-7D4841D5-0862-478C-8F02-B5214A4367BDQ33540684-7393872C-3B64-4893-9C87-F4749027BFBEQ34033553-3C24EF73-4F72-431E-B5D4-34A3192455F5Q34232835-41415E06-AB21-4E4F-BB68-B475839AC579Q34463602-A1843627-51F6-461F-9449-40B256D19E9CQ35054475-006C5BF7-710C-4B3B-91F9-DFE0184D8C23Q35112222-80F13616-25C2-4103-8F0F-2916D9811E6BQ36059652-AFA44F52-D3C4-40C3-9B26-568BE8EB4C6DQ36092021-DF6CDE97-487A-408D-BDD2-A3298963AA48Q36588337-4177489C-FF77-4F71-99DA-F668950D4663Q36658236-320BC60E-7ACF-4E9A-84CA-EC6C92EA5E61Q36759585-CDD8A0C0-4993-4432-A283-095DD1E65619Q36800530-6DDA1C9D-4829-4804-9E4B-FE7E3191CA4AQ36923436-996D5DC6-9252-47B0-8769-4E199ECD3D5BQ37075874-BC751BF4-A466-460B-A9D2-EA8F1831F61FQ37078261-0DAB8335-69D7-4FED-AC9F-77F732A0BFC2Q37424438-E66A8332-F81B-4F28-B6E4-CA01CE255042Q37607977-04A66476-74DC-4A3A-8186-7B6B8C0722BAQ37607984-128CA6D9-1A2C-4B68-970C-877BA432FF11Q38010596-9C9912B9-0A24-4426-9171-A4B1D8DB2920Q38416371-B4768909-2832-453F-A9F5-8D7A50F23FFDQ38730402-D0E2D6C2-8987-4F6F-89F4-F6DB4E31B719Q38743140-694488DE-6E30-4AA3-9EE4-914B2B62D20EQ40522102-D348E434-3AD4-43CE-9183-BC84958C34F1Q44158585-56E29ECD-48D3-432E-9A7E-167B92C84D91Q46314776-24460F77-FC25-4EEB-AFF0-1B6CA47F4263Q46910457-12EECCAE-45B4-45C2-B1B0-D5B360955598Q48238787-EE4AC005-2B03-453E-92F0-84F463F7E310Q53057732-0D0E4E14-1780-4E87-B8F8-8366600BD0AFQ57918775-2E927E96-A17D-4C59-B00B-5A3266AE660F
P2860
Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Successful engraftment after r ...... vanced hematological diseases.
@en
type
label
Successful engraftment after r ...... vanced hematological diseases.
@en
prefLabel
Successful engraftment after r ...... vanced hematological diseases.
@en
P2093
P1476
Successful engraftment after r ...... vanced hematological diseases.
@en
P2093
Eiji Kusumi
Jun-Ichi Ueyama
Kazuhiko Kobayashi
Koichiro Yuji
Masahiro Kami
Mineo Kanemaru
Naoko Murashige
Shigeru Masuo
Shigesaburo Miyakoshi
Shin-Ichiro Mori
P304
P356
10.1158/1078-0432.CCR-03-0754
P407
P577
2004-06-01T00:00:00Z